Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IM Cannabis Corp.

IM Cannabis Corp. (IMCC) Stock Overview

Explore IM Cannabis Corp.’s financial performance, market position, analyst ratings, and future outlook.

IMCC●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.23
$2.49(143.10%)
U.S. Market opens in 55h 35m

IM Cannabis Corp. (IMCC)

Meyka AI Score

Z

Key Financials

Market Cap2.6M
P/E Ratio-0.17
EPS (TTM)$-1.75
ROE8.42%
Fundamental Analysis

AI Price Forecasts

1 Month$3.17
3 Months$0.06
1 Year Target$9.67

IMCC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IM Cannabis Corp. (NASDAQ: IMCC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, IM Cannabis Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IMCC on the NASDAQ shows an RSI of 76.31, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $9.67 for the NASDAQ listing.

Key metrics behind IM Cannabis Corp.'s NASDAQ-traded stock include a P/E ratio of -0.17 and a market capitalization of 2.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IMCC on the NASDAQ.

Price Performance (NASDAQ: IMCC)

1-Day Change
143.10%
5-Day Change
141.71%
1-Month Change
34.29%
3-Month Change
-22.10%
6-Month Change
-77.26%
Year-to-Date (YTD) Change
-89.86%
1-Year Change
-92.84%
3-Year Change
-96.38%
5-Year Change
-99.92%
All-Time (Max) Change
-99.88%

Contact Information

https://www.imcannabis.com
972 5 44331111
3606 – 833 Seymour Street, Vancouver, BC, V6B 0G4

Company Facts

440 Employees
IPO DateMay 20, 2020
CountryCA
Actively Trading

Frequently Asked Questions